Rigel Pharmaceuticals Inc (RIGL)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
Apr 23, 16:00
1.135
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Gross Profit Margin (Quarterly): 89.41% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 89.41% |
| September 30, 2023 | 95.49% |
| June 30, 2023 | 96.00% |
| March 31, 2023 | 96.25% |
| December 31, 2022 | 99.33% |
| September 30, 2022 | 98.88% |
| June 30, 2022 | 96.53% |
| March 31, 2022 | 99.28% |
| December 31, 2021 | 97.61% |
| September 30, 2021 | 99.30% |
| June 30, 2021 | 99.51% |
| March 31, 2021 | 99.61% |
| Date | Value |
|---|---|
| December 31, 2020 | 98.26% |
| September 30, 2020 | 99.24% |
| June 30, 2020 | 98.26% |
| March 31, 2020 | 99.72% |
| December 31, 2019 | 98.84% |
| September 30, 2019 | 98.51% |
| June 30, 2019 | 97.01% |
| March 31, 2019 | 99.15% |
| December 31, 2018 | 99.50% |
| September 30, 2018 | 98.58% |
| June 30, 2018 | 98.32% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
89.41%
Minimum
Dec 2023
99.72%
Maximum
Mar 2020
97.74%
Average
98.51%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | 69.51% |
| Avid Bioservices Inc | -18.37% |
| Stereotaxis Inc | 59.98% |
| Cara Therapeutics Inc | 79.76% |
| Blueprint Medicines Corp | 99.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -20.65% |
| Return on Invested Capital | -82.92% |
| Profit Margin (Quarterly) | 2.06% |
| Operating Margin (Quarterly) | 5.49% |
| Return on Net Operating Assets | -47.00% |